EGROS FABRICE sold 49.4% of their position (15.63K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $246.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2021ACC: 0001562180-21-005491
-15.63K
Net shares
Net seller
$246.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15.63K acquired · 31.27K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15.63K
Price / share
$7.88
Trade value
$123.20K
% of position
97.7%
8/18/2021
16K→31.64K
Common Stock
Direct
Shares
−15.63K
Price / share
$15.75
Trade value
$246.33K
% of position
49.4%
8/18/2021
31.64K→16K
Total
Net shares
+0.00
Net value
-$123.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2021 | M · Option Exercise | +15.63K | $7.88 | $123.20K | 97.7% | 16K | 31.64K |
| Common Stock Direct | 8/18/2021 | S · Sale | −15.63K | $15.75 | $246.33K | 49.4% | 31.64K | 16K |
| Total | +0.00 | -$123.12K | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
0.00 shares
Shares
−15.63K
Strike price
7.88
Held after
0.00
Exercisable
—
8/18/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock0.00 shares | 8/18/2021 | M · Option Exercise | −15.63K | 7.88 | — | 0.00 |